Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Virus Res

Retrieve available abstracts of 13 articles:
HTML format

Single Articles

    November 2021
  1. XIAO T, Leng H, Zhang Q, Chen Q, et al
    Isolation and characterization of a Sabin 3/Sabin 1 recombinant vaccine-derived poliovirus from a child with severe combined immunodeficiency.
    Virus Res. 2021 Nov 15:198633. doi: 10.1016/j.virusres.2021.198633.
    PubMed     Abstract available

    August 2021
  2. HU J, Li G, Xi W, Cai L, et al
    Development of a subunit vaccine based on fiber2 and hexon against fowl adenovirus serotype 4.
    Virus Res. 2021 Aug 26:198552. doi: 10.1016/j.virusres.2021.198552.
    PubMed     Abstract available

    July 2021
  3. RAYCHOUDHURI A, Naru AK, Kanubothula SR, Uddala R, et al
    Development of an experimental inactivated vaccine from Vero cell adapted Enterovirus D68.
    Virus Res. 2021 Jul 30:198528. doi: 10.1016/j.virusres.2021.198528.
    PubMed     Abstract available

    June 2021
    Viral Vector DNA- and RNA-Based SARS-CoV-2 Vaccines: Possible Integration into the Human Genome Are Adenoviral Genes Expressed in Vector-based Vaccines?
    Virus Res. 2021 Jun 1:198466. doi: 10.1016/j.virusres.2021.198466.
    PubMed     Abstract available

    May 2021
  5. CARNEIRO DC, Sousa JD, Monteiro-Cunha JP
    The COVID-19 Vaccine Development: A Pandemic Paradigm.
    Virus Res. 2021 May 17:198454. doi: 10.1016/j.virusres.2021.198454.
    PubMed     Abstract available

    April 2021
  6. ROY S, Ghani K, de Campos-Lima PO, Caruso M, et al
    A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein.
    Virus Res. 2021;295:198305.
    PubMed     Abstract available

    March 2021
  7. LARIJANI MS, Ramezani A, Shirazi MMA, Bolhassani A, et al
    Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine.
    Virus Res. 2021 Mar 25:198403. doi: 10.1016/j.virusres.2021.198403.
    PubMed     Abstract available

  8. LANDGRAF G, Desheva YA, Rudenko LG
    Evaluation of influenza A and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines.
    Virus Res. 2021 Mar 17:198396. doi: 10.1016/j.virusres.2021.198396.
    PubMed     Abstract available

    January 2021
  9. ANWAR MN, Guo S, Xin W, Hameed M, et al
    Adaptation of a live-attenuated genotype I Japanese encephalitis virus to vero cells is associated with mutations in structural protein genes.
    Virus Res. 2021;292:198256.
    PubMed     Abstract available

    November 2020
  10. KIM SW, Kim SJ, Oh MJ
    Efficacy of live NNV immersion vaccine immunized at low temperature in sevenband grouper, Epinephelus septemfasciatus.
    Virus Res. 2020 Nov 10:198227. doi: 10.1016/j.virusres.2020.198227.
    PubMed     Abstract available

    October 2020
  11. SITARAS I, Spackman E, de Jong MCM, Parris DJ, et al
    Selection and Antigenic Characterization of Immune-Escape Mutants of H7N2 Low Pathogenic Avian Influenza Virus Using Homologous Polyclonal Sera.
    Virus Res. 2020 Oct 9:198188. doi: 10.1016/j.virusres.2020.198188.
    PubMed     Abstract available

    August 2020
  12. WENJUN M
    Swine Influenza Virus: Current Status and Challenge.
    Virus Res. 2020 Aug 13:198118. doi: 10.1016/j.virusres.2020.198118.
    PubMed     Abstract available

    June 2020
  13. GAO X, Zhao D, Zhou P, Zhang L, et al
    Characterization, pathogenicity and protective efficacy of a cell culture-derived porcine deltacoronavirus.
    Virus Res. 2020;282:197955.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.